Key facts
- Notable investors include Tech Incubator Program for Startup, Smilegate Investment, Center for Creative Economy and Innovation, Korea Technology Finance, BiiG WAVE — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for PearlsInMires
- ·The full record, as it builds
Funding rounds
No funding rounds for PearlsInMires are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PearlsInMires
Developer of pharmaceutical research intended to support the development of therapeutic compounds related to cancer and related conditions. The company offers cancer drugs that investigate molecular compounds and their biological effects, enabling exploration of anticancer drug candidates and related biochemical interventions.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2023
- Website
- pearlsinmires.com/
- Ownership
- Privately Held (backing)
PearlsInMires doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PearlsInMires shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PearlsInMires in its N-PORT filings yet. We sweep new filings monthly.